Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Early Parkinson Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT06015841
What this trial is testing

Evaluate the Effects of ACI-7104.056 in Patients With Early Stages of Parkinson's Disease

Who this might be right for
Parkinson DiseaseParkinson Disease 6, Early-Onset
AC Immune SA 150
Testing effectiveness (Phase 2)UnknownNCT01560754
What this trial is testing

Disease-modifying Potential of Transdermal NICotine in Early Parkinson's Disease

Who this might be right for
Parkinson's Disease
James BOYD MD 160
Testing effectiveness (Phase 2)Study completedNCT00004731
What this trial is testing

Parkinson's Disease Treatment With Coenzyme Q10

Who this might be right for
Parkinson's Disease
National Institute of Neurological Disorders and Stroke (NINDS)
Testing effectiveness (Phase 2)Study completedNCT04995081
What this trial is testing

Clinical Trial for Parkinson's Disease Using Allogeneic HB-adMSCs (Early and Moderate PD)

Who this might be right for
Parkinson Disease
Hope Biosciences Research Foundation 60
Not applicableStudy completedNCT02511015
What this trial is testing

Hereditary Parkinson s Disease Natural History Protocol

Who this might be right for
Parkinson Disease 6, Early-OnsetParkinson Disease (Autosomal Recessive, Early Onset) 7, HumanParkinson Disease Autosomal Recessive, Early Onset+1 more
National Heart, Lung, and Blood Institute (NHLBI) 31
Large-scale testing (Phase 3)UnknownNCT05830396
What this trial is testing

GRoningen Early-PD Ambroxol Treatment

Who this might be right for
ParkinsonParkinson Disease
University Medical Center Groningen 80
Large-scale testing (Phase 3)Study completedNCT02337725
What this trial is testing

TVP-1012 (1 mg) in Early Parkinson's Disease Patients

Who this might be right for
Parkinson's Disease
Takeda 244
Large-scale testing (Phase 3)Study completedNCT00558025
What this trial is testing

Overnight Switch Trial From Pramipexole IR to Pramipexole ER in Patients With Early Parkinson Disease

Who this might be right for
Parkinson Disease
Boehringer Ingelheim 156
Not applicableStudy completedNCT05308238
What this trial is testing

Pre-Active PD: Looking At Physical Activity Behavior Change in Parkinson's Disease

Who this might be right for
Parkinson Disease
San Jose State University 50
Not applicableUnknownNCT02100176
What this trial is testing

MIRT and Rotigotine in the Early Stage of PD

Who this might be right for
Parkinson's Disease
Ospedale Generale Di Zona Moriggia-Pelascini 40
Early research (Phase 1)Study completedNCT05924243
What this trial is testing

Investigate The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7486967 in Participants With Early Idiopathic Parkinson's Disease.

Who this might be right for
Parkinson Disease
Hoffmann-La Roche 60
Not applicableStudy completedNCT03330470
What this trial is testing

Molecular Mediators of Physical Exercise and Carnosine Induced Effects in Patients With Preclinical and Early Stage Neurodegenerative Disease

Who this might be right for
Subjective Cognitive ImpairmentMild Cognitive ImpairmentParkinson Disease+1 more
Slovak Academy of Sciences 26
Not applicableNot Yet RecruitingNCT06155942
What this trial is testing

Early Biomarkers of Neurodegeneration in Parkinsonian Syndromes

Who this might be right for
Parkinson DiseaseProgressive Supranuclear Palsy
Assistance Publique Hopitaux De Marseille 63
Testing effectiveness (Phase 2)Study completedNCT01538329
What this trial is testing

Amantadine and L-DOPA-induced Dyskinesia in Early Parkinson's Disease

Who this might be right for
Parkinson Disease
University Hospital, Toulouse 210
Testing effectiveness (Phase 2)Active Not RecruitingNCT04218968
What this trial is testing

Cardiac Changes in Early Parkinson's Disease: A Follow up Study

Who this might be right for
REM Sleep Behavior DisorderPre-motor Parkinson DiseaseSymptomatic Parkinson Disease
Cedars-Sinai Medical Center 15
Early research (Phase 1)Looking for participantsNCT06608355
What this trial is testing

The Safety, Tolerability and Preliminary Efficacy of NouvNeu001 for Early-onset Parkinson's Disease

Who this might be right for
Early-onset Parkinson's Disease
iRegene Therapeutics Co., Ltd. 6
Testing effectiveness (Phase 2)UnknownNCT03230526
What this trial is testing

Identification of a Biomarker Predictive of Evolution of Parkinson Disease

Who this might be right for
Parkinson Disease
Nantes University Hospital 31
Not applicableUnknownNCT03047408
What this trial is testing

Evolution of RBD in PD

Who this might be right for
REM Sleep Behavior DisorderParkinson's Disease
University Hospital, Clermont-Ferrand 50
Early research (Phase 1)Looking for participantsNCT07840027
What this trial is testing

Assessment of the Safety, Immunogenicity, and Pharmacodynamics of TRB-001 in Patients With Early Idiopathic Parkinson's Disease

Who this might be right for
Parkinson Disease (PD)Idiopathic Parkinson's Disease
Tridem Bioscience FlexCo 36
Post-approval studies (Phase 4)Study completedNCT00402233
What this trial is testing

A Randomized, Double-blind, Active (Pramipexole 0.5 mg Tid) and Placebo Controlled, Study of Pramipexole Given 0.5 mg and 0.75 mg Bid Over 12-week Treatment in Early Parkinson's Disease (PD) Patients

Who this might be right for
Parkinson Disease
Boehringer Ingelheim 312
Next Page